| 000 -LEADER |
|---|
| fixed length control field |
01641cam a2200265 a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20171214144427.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120305s2012 flua b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781439845677 (hardback : alk. paper) |
| 041 07 - Language |
|---|
| Language code of text/sound track or separate title |
eng |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.704 |
| Edition number |
23 |
| Item number |
G123 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gad, Shayne C., |
| Dates associated with a name |
1948- |
| 9 (RLIN) |
13724 |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Safety pharmacology in pharmaceutical development : |
| Remainder of title |
approval and post marketing surveillance / |
| Statement of responsibility, etc |
Shayne C. Gad. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Boca Raton, FL : |
| Name of publisher, distributor, etc |
CRC Press, |
| Date of publication, distribution, etc |
2012. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xv, 197 p. : |
| Other physical details |
ill. ; |
| Dimensions |
24 cm. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Evaluation, Preclinical. |
| 9 (RLIN) |
13467 |
|
|---|
| Topical term or geographic name as entry element |
Drug Approval. |
| 9 (RLIN) |
5325 |
|
|---|
| Topical term or geographic name as entry element |
Product Surveillance, Postmarketing. |
| 9 (RLIN) |
30844 |
|
|---|
| Topical term or geographic name as entry element |
Toxicity Tests. |
| 9 (RLIN) |
35402 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gad, Shayne C., |
| Dates associated with a name |
1948- |
| Title of a work |
Safety pharmacology in pharmaceutical development and approval. |
| 9 (RLIN) |
13724 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
Book |
